RecallRadar

FDA Drug recall D-0871-2026

Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with Hang Tag, 0.5 fl oz…

On 2026-09-30 the FDA classified a Class II recall of Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with Hang Tag, 0.5 fl oz… by Insight Pharmaceuticals A Prestige Consumer Healthcare, citing lack of Assurance of Sterility.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0871-2026
ClassificationClass II
Statusongoing
Initiated2026-09-15
Published2026-09-30
Last updated2026-10-06 05:30 UTC
CompanyInsight Pharmaceuticals A Prestige Consumer Healthcare
DistributionUS

Product

Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with Hang Tag, 0.5 fl oz (15mL) per dropper bottle, STERILE, Dist. by Medtech Products Inc., Tarrytown, NY 10591. NDC: 67172-797-15

Reason

Lack of Assurance of Sterility

Identifiers

code_infoLot #: RL25G04, Exp. Date 07/2027; RL2H02, Exp. Date 08/2027.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-10-06 05:30 UTC. Current status: ongoing.

Other recalls by Insight Pharmaceuticals A Prestige Consumer Healthcare

All Insight Pharmaceuticals A Prestige Consumer Healthcare recalls

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0871-2026%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.